Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Influenza
Tetanus
NITAG documentation
Scientific publications
2020
Clear all
Type of publications
NITAG documentation
(89)
SAGE documentation
(3)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(151)
Topics
Agenda & Minutes
(10)
Background paper
(48)
Functioning
(1)
Recommendation
(30)
Available to download in languages
English (EN)
(70)
French (FR)
(11)
Spanish (ES)
(10)
Dutch (NL)
(1)
Regions
Africa
(1)
Americas
(66)
Europe
(20)
South-East Asia
(1)
Western Pacific
(2)
Countries
Diseases
COVID-19
(83)
Influenza
(8)
Tetanus
(1)
Diphtheria
(1)
Ebola
(3)
Hepatitis A
(1)
Hepatitis B
(1)
Human papillomavirus (HPV)
(6)
Meningococcal disease
(1)
Pertussis
(1)
Pneumococcal disease
(3)
Poliomyelitis
(3)
Rotavirus
(1)
Tuberculosis
(1)
Typhoid
(1)
Yellow fever
(1)
Vaccine topics
Target population
Healthcare workers
(3)
Older adults
(2)
Risk group
(3)
Publication date
2020
(90)
2024
(3)
2023
(26)
2022
(81)
2021
(165)
2019
(19)
2018
(16)
2017
(9)
2016
(17)
2015
(14)
2014
(16)
2013
(6)
2012
(3)
2011
(8)
2010
(25)
2009
(15)
2008
(3)
2007
(4)
2006
(2)
2005
(2)
90 results found
2020
∙
Mary Chamberland, ACIP
Ethical Principles for Phased Allocation of COVID-19 Vaccines
2020
∙
Sara Oliver, ACIP
EtR Framework: Moderna COVID-19 vaccine
2020
∙
ACIP, Sara Oliver
EtR Framework: Public Health Problem, Resource Use and Equity Domains
2020
∙
Sara Oliver, ACIP
EtR Framework: Values, Acceptability and Feasibility Domains
2020
∙
Sara Oliver, ACIP
Evidence to Recommendations Framework: Pfizer-BioNTech COVID-19 vaccine
2020
∙
Health Council of the Netherlands
Executive summary of the COVID-19 and vaccination against pneumococci (2)
2020
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Moderna COVID-19 Vaccine
2020
∙
Julia Gargano, ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Pfizer BioNTech COVID-19 Vaccine
2020
∙
NACI
Guidance for influenza vaccine delivery in the presence of COVID-19
2020
∙
NACI, Public Health Agency of Canada
Guidance on the prioritization of initial doses of COVID-19 vaccine(s)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register